PMV Pharmaceuticals, Inc. (PMVP)
1.27
-0.04
(-2.68%)
USD |
NASDAQ |
Oct 23, 16:00
1.275
0.00 (0.00%)
After-Hours: 20:00
PMV Pharmaceuticals Market Cap : 67.89M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 67.89M |
| October 22, 2026 | 69.77M |
| October 21, 2026 | 72.71M |
| October 20, 2026 | 74.31M |
| October 19, 2026 | 67.09M |
| October 16, 2026 | 64.69M |
| October 15, 2026 | 68.96M |
| October 14, 2026 | 66.29M |
| October 13, 2026 | 72.17M |
| October 12, 2026 | 75.38M |
| October 09, 2026 | 81.26M |
| October 08, 2026 | 79.66M |
| October 07, 2026 | 80.19M |
| October 06, 2026 | 86.07M |
| October 05, 2026 | 95.16M |
| October 02, 2026 | 95.69M |
| October 01, 2026 | 93.56M |
| September 30, 2026 | 89.28M |
| September 29, 2026 | 76.45M |
| September 28, 2026 | 72.71M |
| September 25, 2026 | 71.10M |
| September 24, 2026 | 71.37M |
| September 23, 2026 | 73.24M |
| September 22, 2026 | 80.73M |
| September 21, 2026 | 78.85M |
| Date | Value |
|---|---|
| September 18, 2026 | 80.19M |
| September 17, 2026 | 78.05M |
| September 16, 2026 | 76.45M |
| September 15, 2026 | 72.71M |
| September 14, 2026 | 78.05M |
| September 11, 2026 | 74.84M |
| September 10, 2026 | 76.98M |
| September 09, 2026 | 73.51M |
| September 08, 2026 | 71.64M |
| September 04, 2026 | 68.96M |
| September 03, 2026 | 66.29M |
| September 02, 2026 | 67.36M |
| September 01, 2026 | 68.96M |
| August 31, 2026 | 64.69M |
| August 28, 2026 | 65.22M |
| August 27, 2026 | 66.29M |
| August 26, 2026 | 70.03M |
| August 25, 2026 | 69.77M |
| August 24, 2026 | 69.77M |
| August 21, 2026 | 71.10M |
| August 20, 2026 | 69.50M |
| August 19, 2026 | 68.43M |
| August 18, 2026 | 66.29M |
| August 17, 2026 | 66.83M |
| August 14, 2026 | 67.36M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.396B |
| Alnylam Pharmaceuticals, Inc. | 29.96B |
| Anika Therapeutics, Inc. | 286.66M |
| Savara, Inc. | 866.79M |
| Vericel Corp. | 2.176B |
Market Cap Related Metrics
| Price to Book Value | 0.9496 |
| Price | 1.27 |
| Earnings Yield | -111.3% |